Scholarlink

<p>Recent advances in antimicrobial therapy have led to the development of several novel antibiotics that have substantially improved outcomes in infections caused by resistant pathogens. However, these therapeutic gains are not without risk. An underrecognized concern is the sodium content of certain intravenous antibiotics, which may significantly contribute to total daily sodium intake and, in some cases, exceed recommended physiological limits. This additional sodium burden may be clinically relevant in sodium-sensitive populations, including patients with heart failure, chronic kidney disease, or liver cirrhosis. <i>Greater awareness of this factor may help clinicians individualize antimicrobial therapy and may reduce avoidable volume- and electrolyte-related complications</i>,<i> particularly in vulnerable patients.</i></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Sodium load in novel antibiotics – an underrecognized factor in clinical settings

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月16日

查看全文
  • Muhammad Ahmad,
  • Abdul Wasay,
  • Fatima Khan,
  • Nimra Mukhtar Awan

摘要

Recent advances in antimicrobial therapy have led to the development of several novel antibiotics that have substantially improved outcomes in infections caused by resistant pathogens. However, these therapeutic gains are not without risk. An underrecognized concern is the sodium content of certain intravenous antibiotics, which may significantly contribute to total daily sodium intake and, in some cases, exceed recommended physiological limits. This additional sodium burden may be clinically relevant in sodium-sensitive populations, including patients with heart failure, chronic kidney disease, or liver cirrhosis. Greater awareness of this factor may help clinicians individualize antimicrobial therapy and may reduce avoidable volume- and electrolyte-related complications, particularly in vulnerable patients.